Company profile ARAV
After 34 days of this quarter the interest is at 56.0. Based on that we can calculate that during remaining 58 days it will total up to 152.0. Aravive expected interest is significantly lower compared to previous quarter (-56.3%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 63 |
| 2019 | 195 209.5% QoQ | 75 -61.5% QoQ | 95 26.7% QoQ | 175 177.8% YoY 84.2% QoQ |
| 2020 | 153 -21.5% YoY -12.6% QoQ | 161 114.7% YoY 5.2% QoQ | 237 149.5% YoY 47.2% QoQ | 111 -36.6% YoY -53.2% QoQ |
| 2021 | 175 14.4% YoY 57.7% QoQ | 174 8.1% YoY -0.6% QoQ | 74 -68.8% YoY -57.5% QoQ | 157 41.4% YoY 112.2% QoQ |
| 2022 | 135 -22.9% YoY -14.0% QoQ | 157 -9.8% YoY 16.3% QoQ | 103 39.2% YoY -34.4% QoQ | 130 -17.2% YoY 26.2% QoQ |
| 2023 | 71 -47.4% YoY -45.4% QoQ | 102 -35.0% YoY 43.7% QoQ | 348 237.9% YoY 241.2% QoQ | 56 -56.9% YoY -83.9% QoQ |
The average 5 years interest of Aravive was 11.29 per week. The last year interest of Aravive compared to the last 5 years has changed by 9.57%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 39.46%.
There is not enough data for Aravive batiraxcept to provide analysis
There is not enough data for Aravive batiraxcept to provide correlation calculation
There is not enough data for Aravive batiraxcept to provide analysis
There is not enough data for Aravive AVB-S6 to provide analysis
There is not enough data for Aravive AVB-S6 to provide correlation calculation
There is not enough data for Aravive AVB-S6 to provide analysis
There is not enough data for Aravive clinical trials to provide analysis
There is not enough data for Aravive clinical trials to provide correlation calculation
There is not enough data for Aravive clinical trials to provide analysis
There is not enough data for Aravive cancer treatment to provide analysis
There is not enough data for Aravive cancer treatment to provide correlation calculation
There is not enough data for Aravive cancer treatment to provide analysis
There is not enough data for Aravive pancreatic cancer to provide analysis
There is not enough data for Aravive pancreatic cancer to provide correlation calculation
There is not enough data for Aravive pancreatic cancer to provide analysis
There is not enough data for Aravive ovarian cancer to provide analysis
There is not enough data for Aravive ovarian cancer to provide correlation calculation
There is not enough data for Aravive ovarian cancer to provide analysis
There is not enough data for Aravive fibrosis treatment to provide analysis
There is not enough data for Aravive fibrosis treatment to provide correlation calculation
There is not enough data for Aravive fibrosis treatment to provide analysis
After 39 days of this quarter the interest is at 102.0. Based on that we can calculate that during remaining 52 days it will total up to 238.0. Aravive -stock expected interest is significantly higher compared to previous quarter (+49.7%) and same quarter last year (+221.6%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 152 | 145 -4.6% QoQ | 121 -16.6% QoQ | 189 56.2% QoQ |
| 2020 | 196 28.9% YoY 3.7% QoQ | 72 -50.3% YoY -63.3% QoQ | 141 16.5% YoY 95.8% QoQ | 223 18.0% YoY 58.2% QoQ |
| 2021 | 214 9.2% YoY -4.0% QoQ | 178 147.2% YoY -16.8% QoQ | 190 34.8% YoY 6.7% QoQ | 20 -91.0% YoY -89.5% QoQ |
| 2022 | 213 -0.5% YoY 965.0% QoQ | 168 -5.6% YoY -21.1% QoQ | 131 -31.1% YoY -22.0% QoQ | 180 800.0% YoY 37.4% QoQ |
| 2023 | 74 -65.3% YoY -58.9% QoQ | 146 -13.1% YoY 97.3% QoQ | 282 115.3% YoY 93.2% QoQ | 159 -11.7% YoY -43.6% QoQ |
| 2024 | 102 37.8% YoY -35.8% QoQ | - | - | - |
The average 5 years interest of Aravive -stock was 12.63 per week. The last year interest of Aravive -stock compared to the last 5 years has changed by 4.91%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 0.61%.